M. Tintoré

发表

Responsiveness and predictive value of EDSS and MSFC in primary progressive MS

X. Montalban, C. Polman, B. Uitdehaag, 2008, Neurology.

Relevance of brain lesion distribution and frequency to the subsequent conversion of a clinically isolated syndrome to multiple sclerosis

M. Battaglini, O. Ciccarelli, M. Filippi, 2011 .

MRI criteria for MS in patients with clinically isolated syndromes

F. Barkhof, N. De Stefano, M. Rovaris, 2010, Neurology.

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

F. Barkhof, M. Filippi, M. Rocca, 2015, Nature Reviews Neurology.

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis

F. X. Aymerich, À. Rovira, X. Montalban, 2017, American Journal of Neuroradiology.

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

F. Barkhof, M. Filippi, M. Rocca, 2015, Nature Reviews Neurology.

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis

Massimo Filippi, Christian Enzinger, Frederik Barkhof, 2019, NeuroImage: Clinical.

New diagnostic criteria for multiple sclerosis

J Sastre-Garriga, À. Rovira, X. Montalban, 2003, Neurology.

Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields

A. Oliver, À. Rovira, X. Montalban, 2016, American Journal of Neuroradiology.

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

M. Battaglini, O. Ciccarelli, F. Barkhof, 2020, Nature Reviews Neurology.

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

M. Duddy, M. Tintoré, A. Uccelli, 2016, Patient preference and adherence.

Unraveling treatment response in multiple sclerosis

O. Ciccarelli, F. Barkhof, N. De Stefano, 2018, Neurology.

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

M. Tintoré, Y. Blanco, J. Rodríguez-García, 2021 .

Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses

À. Rovira, M. Tintoré, A. Saiz, 2016, Multiple sclerosis.

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS

À. Rovira, X. Montalban, M. Tintoré, 2014, Multiple sclerosis.

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2017, American Journal of Neuroradiology.

Value of NMO-IgG determination at the time of presentation as CIS

À. Rovira, X. Montalban, M. Tintoré, 2012, Neurology.

New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode

À. Rovira, X. Montalban, E. Sánchez, 2003 .

Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis

M. Filippi, M. Duddy, M. Trojano, 2021, Journal of Neurology.

Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years.

C. Pozzilli, B. Uitdehaag, D. Pelletier, 2020, Multiple sclerosis and related disorders.

Fatigue in multiple sclerosis persists over time: a longitudinal study.

X. Montalban, N. Téllez, M. Tintoré, 2006, Journal of neurology.

Peripheral neuropathy in association with insulinoma: clinical features and neuropathology of a new case.

M. Tintoré, J. Crespo, A. Codina, 1994, Journal of neurology, neurosurgery, and psychiatry.

Lower motor neuron disease in a HIV-2 infected woman

X. Montalban, J. Sastre-Garriga, M. Tintoré, 2000, Journal of Neurology.

Multiple sclerosis in the Middle East and North Africa region

S. Khoury, M. Tintoré, 2020, Multiple sclerosis journal - experimental, translational and clinical.

Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition?

R. Simó, M. Tintoré, J. Mesa, 2000, Journal of the Neurological Sciences.

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

F. Matesanz, X. Montalban, F. Reverter, 2012, Multiple sclerosis.

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2012, European journal of neurology.

Symptom tracking: from clinically isolated syndrome to advanced multiple sclerosis.

M. Tintoré, 2016, Neurodegenerative disease management.

Significant clinical worsening after natalizumab withdrawal: Predictive factors

À. Rovira, X. Montalban, J. Sastre-Garriga, 2015, Multiple sclerosis.

À. Rovira, M. Tintoré, A. Saiz, 2015, Multiple sclerosis.

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

X. Montalban, J. Sastre-Garriga, M. Tintoré, 2003, Multiple sclerosis.

Low‐dose steroids reduce flu‐like symptoms at the initiation of IFNP‐1b in relapsing‐remitting MS

X. Montalban, M. Tintoré, M. Tintoré, 1998, Neurology.

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.

À. Rovira, X. Montalban, J. Sastre-Garriga, 2011, Revista de neurologia.

Amelioration of flulike symptoms at the onset of interferon β‐ 1b therapy in multiple sclerosis by low‐dose oral steroids is related to a decrease in interleukin‐6 induction

X. Montalban, M. Tintoré, M. Tintoré, 1998, Annals of neurology.

[Interobserver variability in the evaluation of functional systems and Kurzke expanded disability status scale in a multiple sclerosis patient].

X. Montalban, M. Tintoré, J. Río, 1996, Revista de neurología (Ed. impresa).

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

F. Barkhof, M. Rovaris, M. Filippi, 2007, Journal of Neurology.

Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.

À. Rovira, X. Montalban, M. Tintoré, 1999, AJNR. American journal of neuroradiology.

Different antiganglioside antibody pattern between relapsing‐remitting and progressive multiple sclerosis

X. Montalban, M. Tintoré, M. Tintoré, 1996, Acta neurologica Scandinavica.

Can the Expanded Disability Status Scale be assessed by telephone?

M. Versavel, X. Montalban, L. Kappos, 2003, Multiple sclerosis.

The potential of serum neurofilament as biomarker for multiple sclerosis

F. Zipp, E. Havrdová, M. Tintoré, 2021, Brain : a journal of neurology.

Will Rogers phenomenon in multiple sclerosis

M. Rovaris, M. Filippi, À. Rovira, 2008, Annals of neurology.

Decreased MMP-9 production in primary progressive multiple sclerosis patients

À. Rovira, X. Montalban, M. Tintoré, 2004, Multiple sclerosis.

Polyglandular autoimmune syndrome type II and multiple sclerosis

X. Montalban, J. Sastre-Garriga, M. Tintoré, 2001, Journal of Neurology.

Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b

X. Montalban, M. Tintoré, J. Río, 1999, Neurology.

Interferon beta in relapsing–remitting multiple sclerosis

X. Montalban, N. Téllez, M. Tintoré, 2005, Journal of Neurology.

[Pituitary apoplexy and empty sella].

R. Simó, M. Tintoré, A. Codina, 1991, Medicina clinica.

[Hypertrophic pachymeningitis. A review of the histories of two cases and pathological relationship with the Tolosa-Hunt syndrome and the orbital pseudotumor].

A. Mauleon, À. Rovira, X. Montalban, 2000, Revista de neurologia.

Response to botulinum toxin in a case of rigid spine syndrome

X. Montalban, J. Sastre-Garriga, M. Tintoré, 2001, Journal of neurology, neurosurgery, and psychiatry.

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

A. Rovira, R. Pelayo, À. Rovira, 2008, Neurology.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

S. Rauch, C. Enzinger, X. Montalban, 2015, Multiple sclerosis.

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

À. Rovira, X. Montalban, N. Téllez, 2008, Journal of Neurology.

Antibodies against gangliosides in patients with SLE and neurological manifestations.

M. Tintoré, M. Vilardell, J. Ordi, 1992, Lupus.

Antibodies against endothelial cells in patients with multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 1996, Acta neurologica Scandinavica.

Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus

J. Vianna, G. Hughes, M. Tintoré, 1992, Neurology.

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

À. Rovira, C. Enzinger, X. Montalban, 2015, Brain : a journal of neurology.

Serum homocysteine levels in multiple sclerosis.

M. Tintoré, J. Río, M. Malinow, 1994, Archives of neurology.

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS

À. Rovira, X. Montalban, M. Tintoré, 2001, Multiple sclerosis.

Interferon beta in secondary progressive multiple sclerosis

X. Montalban, N. Téllez, M. Tintoré, 2007, Journal of Neurology.

Natalizumab for relapsing-remitting multiple sclerosis.

M. Tintoré, A. Horga, 2011, Neurologia.

Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α

X. Montalban, M. Tintoré, O. Fábregues, 1998, Journal of neurology, neurosurgery, and psychiatry.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

O. Ciccarelli, M. Filippi, M. Rocca, 2018, Multiple sclerosis.

Pure sensory stroke due to midbrain haemorrhage.

J. Álvarez-Sabín, M. Tintoré, A. Codina, 1991, Journal of neurology, neurosurgery, and psychiatry.

Family planning considerations in people with multiple sclerosis

S. Vukusic, M. Tintoré, R. Bove, 2023, The Lancet Neurology.

Gadolinium-enhanced brain lesions in multiple sclerosis relapse.

À. Rovira, M. Tintoré, Y. Blanco, 2021, Neurologia.

Anti-VDRL antibodies by ELISA in cerebrospinal fluid and its value in the differential diagnosis of abnormalities of the cerebrospinal fluid.

M. Tintoré, R. Asherson, A. Codina, 1992, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Multiple sclerosis risk perception and acceptance for Brazilian patients.

M. Tintoré, C. Tur, E. M. Oliveira, 2018, Arquivos de neuro-psiquiatria.

Scoring treatment response in patients with relapsing multiple sclerosis

B Stubinski, M. Sormani, X. Montalban, 2013, Multiple sclerosis.

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

À. Rovira, X. Montalban, M. Tintoré, 2008, Multiple sclerosis.

Measures in the first year of therapy predict the response to interferon β in MS

J Sastre-Garriga, À. Rovira, X. Montalban, 2009, Multiple sclerosis.

Baseline MRI predicts future attacks and disability in clinically isolated syndromes

À. Rovira, X. Montalban, M. Tintoré, 2006, Neurology.

Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2006, Multiple sclerosis.

Clinical impact of early brain atrophy in clinically isolated syndromes

J Sastre-Garriga, À. Rovira, X. Montalban, 2013, Multiple sclerosis.

[Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].

À. Rovira, M. Tintoré, G. Izquierdo, 2010, Neurologia.

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

M. Sormani, M. Inglese, D. Pelletier, 2015, Annals of neurology.

Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

À. Rovira, M. Sormani, X. Montalban, 2014, PloS one.

Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load

F. X. Aymerich, J Sastre-Garriga, À. Rovira, 2016, Neuroradiology.

Fatigue in multiple sclerosis persists over time

X. Montalban, N. Téllez, M. Tintoré, 2006, Journal of Neurology.

[Calcified cerebral metastases. Study of two cases and review of literature].

À. Rovira, X. Montalban, J. Montaner, 2000, Neurologia.

The search for responsive clinical endpoints in primary progressive multiple sclerosis

X. Montalban, C. Polman, M. Tintoré, 2009, Multiple sclerosis.

Brainstem lesions in clinically isolated syndromes

À. Rovira, X. Montalban, M. Tintoré, 2010, Neurology.

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

X. Montalban, M. Tintoré, M. Tintoré, 2002, Multiple sclerosis.

X. Montalban, M. Tintoré, L. Brieva, 2001, Multiple sclerosis.

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

D. Reich, P. Vermersch, M. Inglese, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Is optic neuritis more benign than other first attacks in multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2005 .

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

X. Montalban, M. Tintoré, N. Téllez, 2005, Multiple sclerosis.

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

À. Rovira, X. Montalban, E. Grivé, 2000, AJNR. American journal of neuroradiology.

Long-term emotional state of multiple sclerosis patients treated with interferon beta

X. Montalban, M. Tintoré, M. Arévalo, 2006, Multiple sclerosis.

Antibodies against Gangliosides in Patients with SLE and Neurological Manifestations

M. Tintoré, M. Vilardell, J. Ordi, 1992 .

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

AJ Thompson, Z. Khaleeli, X. Montalban, 2010, Multiple sclerosis.

A three-year, multi-parametric MRI study in patients at presentation with CIS

F. Barkhof, M. Filippi, M. Rocca, 2008, Journal of Neurology.

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

À. Rovira, X. Montalban, J. Sastre-Garriga, 2020, American Journal of Neuroradiology.

Early onset multiple sclerosis: The role of gender

M. Tintoré, Georgina Arrambide, Mar Tintoré, 2009, Journal of the Neurological Sciences.

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

F. Barkhof, M. Filippi, M. Rocca, 2014, Multiple sclerosis.

Radiologically isolated syndrome in children

P. Vermersch, D. Pelletier, E. Shapiro, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

M. Tintoré, L. Ramió-Torrentá, G. Izquierdo Ayuso, 2020, Neurologia.

Clinically definite multiple sclerosis after radiological Schilder-like onset

À. Rovira, X. Montalban, J. Sastre-Garriga, 2003, Journal of Neurology.

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis

À. Rovira, X. Montalban, Y. Vives-Gilabert, 2015, American Journal of Neuroradiology.

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

M. Tintoré, Y. Blanco, J. Rodríguez-García, 2020, Neurologia.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

M. Tintoré, L. Ramió-Torrentá, G. Izquierdo Ayuso, 2020, Neurologia.

Rationale for early intervention with immunomodulatory treatments

M. Tintoré, 2008, Journal of Neurology.

C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings

A. Thompson, À. Rovira, X. Montalban, 2003, Multiple sclerosis.

Is optic neuritis more benign than other first attacks in multiple sclerosis?

À. Rovira, X. Montalban, M. Tintoré, 2005, Annals of neurology.

The basal ganglia: a substrate for fatigue in multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2007, Neuroradiology.

Early MS treatment.

M. Tintoré, 2007, International MS journal.

Very early scans for demonstrating dissemination in time in multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2008, Multiple sclerosis.

Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort

À. Rovira, X. Montalban, N. Téllez, 2007, Multiple sclerosis.

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis

Maria Assunta Rocca, Massimo Filippi, Marco Battaglini, 2013, Neurology.

Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2006, Neurology.

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

F. X. Aymerich, À. Rovira, X. Montalban, 2009, Multiple sclerosis.

[Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis].

À. Rovira, X. Montalban, J. Sastre-Garriga, 2008, Neurología.

Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS

À. Rovira, X. Montalban, J. Sastre-Garriga, 2010, Journal of Neurology.

Understanding the role of gender and hormones in multiple sclerosis

M. Tintoré, C. Tur, 2014, Multiple sclerosis.

Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.

M. Tintoré, E. M. Oliveira, D. Bichuetti, 2013, Arquivos de neuro-psiquiatria.

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

À. Rovira, X. Montalban, M. Tintoré, 2004, Journal of Neurology.

[Conversion to clinically definite multiple sclerosis after isolated spinal cord syndrome: value of brain and spinal MRI].

À. Rovira, X. Montalban, M. Tintoré, 2001, Medicina clinica.

New options for early treatment of multiple sclerosis

M. Tintoré, 2009, Journal of the Neurological Sciences.

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

À. Rovira, X. Montalban, M. Tintoré, 2010, Multiple sclerosis.

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome

F. Barkhof, M. Filippi, M. Rocca, 2009, European Radiology.

The immune response against herpesvirus is more prominent in the early stages of MS

X. Montalban, P. Villoslada, M. Tintoré, 2003, Neurology.

[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study].

À. Rovira, X. Montalban, M. Tintoré, 1997, Medicina clinica.

[Optic neuritis, brain stem syndromes and myelitis: rapid conversion to multiple sclerosis].

À. Rovira, X. Montalban, M. Tintoré, 1999, Medicina clinica.

Author response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

M. Tintoré, S. Pérez-Hoyos, S. Otero-Romero, 2020, Neurology.

[Parkinsonian hemi-syndrome as the initial manifestation of supratentorial cystic hemangioblastoma in a patient with Von Hippel-Lindau disease].

X. Montalban, M. Tintoré, J. Vilalta, 1998, Revista de neurologia.

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements

M. Tintoré, C. Oreja-Guevara, J. Prieto, 2023, Cureus.

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.

M. Tintoré, 2015, Neurodegenerative disease management.

Rationale for early intervention with immunomodulatory treatments

M. Tintoré, 2008, Journal of Neurology.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

O. Ciccarelli, M. Filippi, M. Rocca, 2018, Multiple sclerosis.

Validation of a New Semiautomated Segmentation Pipeline Based on the Spinal Cord Toolbox DeepSeg Algorithm to Estimate the Cervical Canal Area

À. Rovira, X. Montalban, J. Sastre-Garriga, 2023, American Journal of Neuroradiology.

Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes

J. Sastre-Garriga, M. Tintoré, 2009, Multiple sclerosis.